Key Metrics
CiteScore 

2
SJR 

Q2Respiratory Care

SNIP 

0.48
Recommended pre-submission checks
Powered by 

Topics Covered on Pulmonary Therapy
Pulmonary Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | EUR 4500 | USD 5600 | GBP 4100 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Pulmonary Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pulmonary Therapy
Practical Considerations for Managing Transitions from Parenteral Prostacyclins to Oral Selexipag in Pulmonary Arterial Hypertension.
- 8 Apr 2026
- Pulmonary therapy
2025 Annual Review of Pulmonary Arterial Hypertension Clinical Research.
- 8 Apr 2026
- Pulmonary therapy
Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Thailand: Epidemiological Data Update.
- 28 Mar 2026
- Pulmonary therapy
Oscillating Positive Expiratory Pressure (OPEP) Therapy in Bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD): A Narrative Review of Clinical Studies.
- 28 Mar 2026
- Pulmonary therapy
Assessment of Clinical Questionnaires for Predicting Obstructive Sleep Apnea in Patients with Non-Valvular Atrial Fibrillation.
- 13 Mar 2026
- Pulmonary therapy
Climate Change and the Switch from Pressurised Metered-Dose Inhalers to Dry Powder Inhalers: A Proportionate Balancing of Risk and Reward?
- 12 Mar 2026
- Pulmonary therapy
Practical Considerations for Managing Transitions from Parenteral Prostacyclins to Oral Selexipag in Pulmonary Arterial Hypertension.
- 8 Apr 2026
- Pulmonary therapy
2025 Annual Review of Pulmonary Arterial Hypertension Clinical Research.
- 8 Apr 2026
- Pulmonary therapy
Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Thailand: Epidemiological Data Update.
- 28 Mar 2026
- Pulmonary therapy
Oscillating Positive Expiratory Pressure (OPEP) Therapy in Bronchiectasis and Chronic Obstructive Pulmonary Disease (COPD): A Narrative Review of Clinical Studies.
- 28 Mar 2026
- Pulmonary therapy
Assessment of Clinical Questionnaires for Predicting Obstructive Sleep Apnea in Patients with Non-Valvular Atrial Fibrillation.
- 13 Mar 2026
- Pulmonary therapy
Climate Change and the Switch from Pressurised Metered-Dose Inhalers to Dry Powder Inhalers: A Proportionate Balancing of Risk and Reward?
- 12 Mar 2026
- Pulmonary therapy